Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clotrimazole vs Fluconazole for Severe Vulvovaginal Candidiasis
NCT02180828Phase 4Completed
- Sponsor
- Peking University Shenzhen Hospital
- Start
- Jul 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clotrimazole in vulvovaginal candidiasis (VVC) (2 arms), sponsored by Peking University Shenzhen Hospital. Primary endpoint: Therapeutic Efficacy. Started Jul 2014; status: completed.
02
Drugs
clotrimazole
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT02180828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180828.